Illinois Rural Healthcare Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 17781 Hornbean Dr, Wildwood, MO 63005 Phone: 312-953-5636 |
Mercy Clinic Convenient Care Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 16555 Manchester Rd Ste 110, Wildwood, MO 63040 Phone: 636-405-3155 Fax: 636-405-3162 |
Idim Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1909 Larimer Trl, Wildwood, MO 63011 Phone: 636-273-5311 |
Altea Medical Missouri Llc Family Medicine - Adult Medicine Medicare: Not Enrolled in Medicare Practice Location: 1441 Charic Dr, Wildwood, MO 63021 Phone: 636-394-2522 |
Wildwood Internal Medicine, Pc Internal Medicine Medicare: Medicare Enrolled Practice Location: 16759 Main Street, Suite 203, Wildwood, MO 63040 Phone: 636-458-4800 Fax: 636-594-7500 |
News Archive
African Americans suffer from cardiovascular diseases at a rate about five times higher than the rest of the U.S. population. In a new study, scientists may have found a culprit: a serious deficiency of nitric oxide, a small molecule vital in the regulation of blood flow and blood pressure.
NAVTEQ, the leading global provider of digital map, traffic and location data for in-vehicle, portable, wireless and enterprise solutions, today announced that the Center for Disease Control and Prevention (CDC) has selected the NAVTEQ® map data for use within its geospatial program, GRASP (Geospatial Research, Analysis, & Services Program).
The National Institutes of Health today released to the scientific community an unparalleled dataset from the Adolescent Brain Cognitive Development study. To date, more than 7,500 youth and their families have been recruited for the study, well over half the participant goal.
When millionaire Silicon Valley real estate developer Bob Klein launched his ballot drive to create a $3-billion state fund for stem-cell research in 2004, he pitched it as a way of taking politics out of science and focusing on cures.
Autifony Therapeutics Limited ("Autifony"), which is pioneering the development of novel pharmaceutical treatments for hearing disorders, today announced that it has been awarded funding of £2.2 million towards a Phase IIa clinical trial in tinnitus patients with its lead compound AUT00063, by the UK's innovation agency, the Technology Strategy Board.
› Verified 1 days ago